Product image of Methylphenidate Hydrochloride Laboratorios Rubio Sa. (Methylphenidate Hydrochloride) supplied by GNH India

Methylphenidate Hydrochloride Laboratorios Rubio Sa.

Active Ingredient:
Methylphenidate Hydrochloride
Origin:
EU

Methylphenidate Hydrochloride Laboratorios Rubio Sa. (Methylphenidate Hydrochloride)

Methylphenidate Hydrochloride, the active ingredient in Methylphenidate Hydrochloride Laboratorios Rubio Sa., is a psychostimulant presented as an oral formulation for oral use. It is prescribed to manage attention deficit hyperactivity disorder and narcolepsy in children, adolescents, and adults.

GNH India supplies Methylphenidate Hydrochloride Laboratorios Rubio Sa. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution. Customers benefit from reliable logistics, batch traceability, and responsive technical support.

Manufacturer / TM Owner

Laboratorios Rubió, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Methylphenidate Hydrochloride is a central nervous system stimulant used in the management of neurodevelopmental and sleep‑wake disorders.

  • Attention deficit hyperactivity disorder (children and adolescents): improves attention, reduces hyperactivity and impulsivity.
  • Attention deficit hyperactivity disorder (adults): enhances focus and executive functioning.
  • Narcolepsy: decreases excessive daytime sleepiness and reduces cataplexy episodes.

How It Works

  • Methylphenidate Hydrochloride blocks the reuptake of dopamine and norepinephrine by inhibiting the dopamine transporter (DAT) and norepinephrine transporter (NET) in neuronal synapses. This increases extracellular concentrations of these catecholamines, enhancing neurotransmission in brain regions that regulate attention, arousal, and impulse control. The elevated catecholamine activity modulates activity in the prefrontal cortex and basal ganglia, which are critical for cognitive processing and motor activity.

Side Effects

Methylphenidate Hydrochloride may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Insomnia: difficulty falling or staying asleep.
  • Decreased appetite: reduced food intake leading to weight loss.
  • Headache: mild to moderate cranial pain.
  • Stomach upset: nausea, abdominal discomfort.

Serious or Rare Side Effects

  • Cardiovascular events: chest pain, hypertension, or arrhythmia.
  • Psychiatric symptoms: new or worsening anxiety, agitation, or psychosis.
  • Growth suppression: prolonged use may affect height development in children.

Precautions & Warnings

When prescribing Methylphenidate Hydrochloride, clinicians should consider several safety precautions.

  • Cardiovascular assessment: evaluate blood pressure and heart history before initiation.
  • Psychiatric evaluation: monitor for anxiety, mood changes, or psychotic symptoms.
  • Substance abuse risk: assess for history of drug misuse or dependence.
  • Growth monitoring: regularly measure height and weight in pediatric patients.
  • Drug interactions: review concomitant medications that affect catecholamine pathways.
  • Store at ambient temperature: keep below 25°C in original packaging, protect from moisture.

Avoid Interactions

Methylphenidate Hydrochloride can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis; avoid concurrent use.
  • Tricyclic antidepressants: may increase cardiovascular side effects.

Moderate Interactions (Monitor Closely)

  • Antihypertensives: methylphenidate may reduce their effectiveness.
  • Proton pump inhibitors: can affect absorption and plasma levels.
  • Anticonvulsants (e.g., carbamazepine): may lower methylphenidate concentrations.
  • SSRIs and SNRIs: may increase risk of serotonin syndrome.

Frequently Asked Questions

Methylphenidate Hydrochloride is prescribed primarily for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. In ADHD it helps improve concentration, reduce hyperactive behavior, and control impulsivity, while in narcolepsy it lessens excessive daytime sleepiness and can reduce cataplexy episodes.

The drug blocks the reuptake of the neurotransmitters dopamine and norepinephrine by inhibiting their transporters in the brain. This raises the levels of these catecholamines in synaptic clefts, enhancing signaling in regions that control attention, wakefulness, and impulse regulation.

Dosing is individualized and must be determined by a qualified prescriber. The healthcare professional considers the patient’s age, weight, severity of symptoms, and response to therapy when establishing the appropriate dose and titration schedule.

Safety data for Methylphenidate in pregnancy and lactation are limited, and the pregnancy category is listed as unknown. Clinicians should weigh potential benefits against possible risks and discuss these considerations with the patient before prescribing.

To request supply, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Methylphenidate and amphetamine‑based stimulants share a similar therapeutic goal of increasing dopamine and norepinephrine activity, but they differ in chemical structure, duration of action, and side‑effect profiles. Some patients respond better to one class over the other, so the choice is guided by clinical response and tolerability.

Store the product at ambient temperature, preferably below 25 °C, in its original container. Keep it away from moisture and direct sunlight, and ensure the packaging remains sealed until use to maintain stability.

The medication is taken orally, usually as a tablet or capsule, and should be swallowed whole with water. It is typically taken once or multiple times per day, according to the prescriber’s instructions, and may be taken with or without food.

Serious concerns include cardiovascular events such as hypertension, chest pain, or arrhythmias, as well as psychiatric effects like new or worsening anxiety, agitation, or psychosis. In children, prolonged therapy may impact growth, so regular monitoring is essential.

Contraindications include known hypersensitivity to methylphenidate, concurrent use of monoamine oxidase inhibitors, severe cardiovascular disease, uncontrolled hypertension, and a history of serious psychiatric disorders. Patients with these conditions should avoid the drug or use it only under strict medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylphenidate Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT